Cancer Genetics Inc (NASDAQ:CGIX)

10.62
Delayed Data
As of Apr 20
 +0.09 / +0.85%
Today’s Change
4.83
Today|||52-Week Range
16.88
+58.98%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2014
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Revenue and IncomeNet Revenues1.4M1.5M3.2M4.0M
 
 
 
 
 
Cost of Goods Sold1.2M1.4M2.3M3.1M
 
 
 
 
 
Depreciation And Amortization103.5K124.4K279.9K--
 
 
 
 
 
Operating ExpensesGross Income140.3K8.6K656.1K905.2K
 
 
 
 
 
General Expenses4.1M4.1M5.2M6.6M
 
 
 
 
 
Research And Development596.8K807.8K1.0M2.2M
 
 
 
 
 
Total Operating Expenses5.4M5.6M7.8M16.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-3.9M-4.1M-4.6M-12.1M
 
 
 
 
 
Extraordinary Credit0.00239.0K129.0K291.0K
 
 
 
 
Extraordinary Charge-44.0K0.000.000.00
 
 
Pre-Tax Equity Earnings---298.0K-349.2K--
 
 
 
Interest Expense On Debt341.2K30.7K36.2K64.7K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-4.3M-4.2M-4.8M-5.7M
 
 
 
 
 
Income Taxes-1.8M0.000.00-536.2K
 
 
 
Net Income-2.5M-4.2M-4.8M-5.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS9.3M9.3M9.6M--
 
 
 
 
Shares To Calculate EPS Diluted9.3M9.3M9.6M--
 
 
 
 
 
Earnings Per ShareEPS-$0.27-$0.47-$0.51-$0.55
 
 
 
 
 
EPS Diluted-$0.27-$0.47-$0.51-$0.54
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account